Mahtani, Reshma http://orcid.org/0000-0002-7711-8627
Niyazov, Alexander
Arondekar, Bhakti
Lewis, Katie
Rider, Alex
Massey, Lucy
Lux, Michael Patrick
Article History
Received: 9 May 2022
Accepted: 16 November 2022
First Online: 22 December 2022
Declarations
:
: Patients provided informed consent for use of their anonymized and aggregated data for research and in scientific publications. Data were aggregated and de-identified before receipt by Adelphi Real World. This research was approved by the Western Institutional Review Board (study protocol AG8643). Data collection was undertaken in line with European Pharmaceutical Marketing Research Association guidelines and, as such, did not require ethics committee approval.
: Not applicable.
: RM has acted as consultant for Agendia, Amgen, AstraZeneca, Daiichi-Sankyo, Eisai, Genentech, Gilead, Hologic, Eli Lilly, Merck, Novartis, Pfizer, Puma, Sanofi, and SeaGen; and has contracted research for AstraZeneca, Genentech, and Veru.AN, BA are employees of and own stock in Pfizer Inc.KL, AR, and LM are employees of Adelphi Real World.MPL has received honoraria for lectures, consulting, and/or working in an advisory role for Eli Lilly, AstraZeneca, MSD, Novartis, Pfizer, Eisai, Exact Sciences, Daiichi-Sankyo, Grünenthal, Gilead, Pierre Fabre, PharmaMar, Onkowissen, and Roche; received fees for travel, accommodations, and/or expenses from Roche and Pfizer; acted as editorial board member of Medac; and received fees for non-CME services from Eli Lilly, Roche, MSD, Novartis, Pfizer, Exact Sciences, Daiichi-Sankyo, Gilead, Grünenthal, AstraZeneca, and Eisai.